Laura Ferrè

2.5k total citations
26 papers, 280 citations indexed

About

Laura Ferrè is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Laura Ferrè has authored 26 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 15 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Laura Ferrè's work include Multiple Sclerosis Research Studies (23 papers), RNA regulation and disease (4 papers) and Polyomavirus and related diseases (4 papers). Laura Ferrè is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), RNA regulation and disease (4 papers) and Polyomavirus and related diseases (4 papers). Laura Ferrè collaborates with scholars based in Italy, France and Sweden. Laura Ferrè's co-authors include Vittorio Martinelli, Federica Esposito, Lucia Moiola, Gıancarlo Comı, Marta Radaelli, B. Colombo, Francesca Sangalli, Massimo Filippi, Filippo Martinelli Boneschi and Valeria Barcella and has published in prestigious journals such as Annals of Neurology, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neurology.

In The Last Decade

Laura Ferrè

24 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Ferrè Italy 10 191 91 57 55 39 26 280
Mariangela D’Onghia Italy 10 226 1.2× 82 0.9× 33 0.6× 69 1.3× 11 0.3× 14 296
Zhiyun Lian China 10 186 1.0× 150 1.6× 50 0.9× 18 0.3× 7 0.2× 22 286
Giuseppe Ribizzi Italy 6 83 0.4× 46 0.5× 21 0.4× 16 0.3× 54 1.4× 10 276
Anna Ticca Italy 12 147 0.8× 214 2.4× 52 0.9× 15 0.3× 15 0.4× 17 448
Lucía Alonso-Magdalena Sweden 9 107 0.6× 27 0.3× 38 0.7× 42 0.8× 4 0.1× 16 204
Bhim Singhal India 14 111 0.6× 147 1.6× 49 0.9× 21 0.4× 5 0.1× 21 506
Shimon Ishida Japan 10 61 0.3× 117 1.3× 23 0.4× 17 0.3× 4 0.1× 35 283
Konstantinos Kilidireas Greece 6 88 0.5× 61 0.7× 32 0.6× 16 0.3× 3 0.1× 8 209
Paige Winokur United States 7 107 0.6× 51 0.6× 91 1.6× 27 0.5× 2 0.1× 8 287
Francesco Antonio Losavio Italy 8 83 0.4× 16 0.2× 14 0.2× 15 0.3× 11 0.3× 13 261

Countries citing papers authored by Laura Ferrè

Since Specialization
Citations

This map shows the geographic impact of Laura Ferrè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Ferrè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Ferrè more than expected).

Fields of papers citing papers by Laura Ferrè

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Ferrè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Ferrè. The network helps show where Laura Ferrè may publish in the future.

Co-authorship network of co-authors of Laura Ferrè

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Ferrè. A scholar is included among the top collaborators of Laura Ferrè based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Ferrè. Laura Ferrè is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pignolet, Béatrice, Elisabetta Mascia, Ferdinando Clarelli, et al.. (2024). DNA Methylation in the Anti‐Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis. Annals of Neurology. 96(2). 289–301. 3 indexed citations
3.
Mascia, Elisabetta, Laura Ferrè, Melissa Sorosina, et al.. (2024). Genetic Contribution to Medium-Term Disease Activity in Multiple Sclerosis. Molecular Neurobiology. 62(1). 322–334. 1 indexed citations
4.
Vezzulli, Paolo, et al.. (2024). Infratentorial posterior reversible encephalopathy syndrome in INFβ1a-treated multiple sclerosis patient. Journal of Neurology. 271(5). 2225–2229.
5.
Clarelli, Ferdinando, Elisabetta Mascia, Melissa Sorosina, et al.. (2024). Vitamin D affects the risk of disease activity in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 96(2). 170–176. 7 indexed citations
6.
Zanetta, Chiara, Maria A. Rocca, Alessandro Meani, et al.. (2023). Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study. Journal of Neurology. 270(7). 3553–3564. 17 indexed citations
7.
Ferrè, Laura, Ferdinando Clarelli, Béatrice Pignolet, et al.. (2023). Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach. Journal of Personalized Medicine. 13(1). 122–122. 6 indexed citations
8.
Sorosina, Melissa, Silvia Santoro, Laura Ferrè, et al.. (2023). Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(3). 5 indexed citations
9.
Ferrè, Laura, Ferdinando Clarelli, Francesca Sangalli, et al.. (2022). Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients. Journal of Neurology. 269(10). 5596–5605.
10.
Clarelli, Ferdinando, Elisabetta Mascia, Silvia Santoro, et al.. (2022). BDNF Val66Met Polymorphism Is Associated With Motor Recovery After Rehabilitation in Progressive Multiple Sclerosis Patients. Frontiers in Neurology. 13. 790360–790360. 9 indexed citations
11.
Sferruzza, Giacomo, Ferdinando Clarelli, Elisabetta Mascia, et al.. (2022). Transcriptional Effects of Fingolimod Treatment on Peripheral T Cells in Relapsing Remitting Multiple Sclerosis Patients. Pharmacogenomics. 23(3). 161–171. 1 indexed citations
12.
Sferruzza, Giacomo, Ferdinando Clarelli, Elisabetta Mascia, et al.. (2021). Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients. Molecular Neurobiology. 58(10). 4816–4827. 9 indexed citations
13.
Boneschi, Filippo Martinelli, Riccardo Curró, Silvia Santoro, et al.. (2020). Impact of multiple sclerosis risk loci in postinfectious neurological syndromes. Multiple Sclerosis and Related Disorders. 44. 102326–102326. 1 indexed citations
14.
Ferrè, Laura, Massimo Filippi, & Federica Esposito. (2020). Involvement of Genetic Factors in Multiple Sclerosis. Frontiers in Cellular Neuroscience. 14. 612953–612953. 11 indexed citations
15.
Sorosina, Melissa, Ferdinando Clarelli, Laura Ferrè, et al.. (2018). Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis. European Journal of Neurology. 25(7). 934–934. 18 indexed citations
16.
Esposito, Federica, Laura Ferrè, Ferdinando Clarelli, et al.. (2018). Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients. Journal of Neurology. 265(4). 896–905. 11 indexed citations
17.
Radaelli, Marta, Lucia Moiola, Francesca Sangalli, et al.. (2015). Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients. Multiple Sclerosis Journal. 22(4). 511–519. 70 indexed citations
18.
Ferrè, Laura, Arturo Nuara, Marta Radaelli, et al.. (2015). Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study. Neurological Sciences. 37(2). 235–242. 35 indexed citations
19.
Sangalli, Francesca, Lucia Moiola, Laura Ferrè, et al.. (2014). Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 3(4). 520–526. 28 indexed citations
20.
Ferrè, Laura, Lucia Moiola, Francesca Sangalli, et al.. (2014). Recurrence of disease activity after repeated Natalizumab withdrawals. Neurological Sciences. 36(3). 465–467. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariangela D’Onghia Breakdown of academic impact, for papers by Zhiyun Lian Breakdown of academic impact, for papers by Giuseppe Ribizzi Breakdown of academic impact, for papers by Anna Ticca Breakdown of academic impact, for papers by Lucía Alonso-Magdalena Breakdown of academic impact, for papers by Bhim Singhal Breakdown of academic impact, for papers by Shimon Ishida Breakdown of academic impact, for papers by Konstantinos Kilidireas Breakdown of academic impact, for papers by Paige Winokur Breakdown of academic impact, for papers by Francesco Antonio Losavio
Rankless by CCL
2026